Prasugrel in critically ill patients

While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoergenhofer, Christian, Hobl, Eva-Luise, Staudinger, Thomas, Speidl, Walter S., Heinz, Gottfried, Siller-Matula, Jolanta, Zauner, Christian, Reiter, Birgit, Kubica, Jacek, Jilma, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Schattauer GmbH 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292180/
https://www.ncbi.nlm.nih.gov/pubmed/28692105
http://dx.doi.org/10.1160/TH17-03-0154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292180/
https://www.ncbi.nlm.nih.gov/pubmed/28692105
http://dx.doi.org/10.1160/TH17-03-0154

Ejemplares similares